The 102-T/C polymorphism of the 5-HT 2A receptor gene was analysed in 159 patients with major depression and 164 unrelated and healthy controls using a case-control design. Allele and genotype frequencies did not differ between cases and controls. No differences according to sex, age of onset, melancholia, suicidal behaviour or family history of psychiatric illness were found. However, genotype distributions significantly differed between patients with seasonal pattern in their episodes (MDS) and patients with no seasonal pattern (N-MDS) ( Alterations in the serotonin system of the central nervous system have classically been related to the origin of depression. Thus, genes encoding proteins involved in the serotoninergic system including the 5-HT transporter and 5-HT 2A are major candidate genes in association studies of major affective disorders.
Alterations in the serotonin system of the central nervous system have classically been related to the origin of depression. Thus, genes encoding proteins involved in the serotoninergic system including the 5-HT transporter and 5-HT 2A are major candidate genes in association studies of major affective disorders.
The 5-HT 2A receptor gene presents a polymorphism (102T/C) that does not result in alteration of the amino acid sequence of the 5-HT 2A receptor protein but has been shown to be in absolute linkage disequilibrium with a polymorphism (−1438A/G) in the promoter region of the gene. However, a functional analysis of −1438A/G polymorphism has failed to demonstrate that this polymorphism influences the transcription of the 5-HT 2A receptor gene. 1 Although no positive results have been found in major affective disorders, [2] [3] [4] studies in other disorders such as anorexia or suicidal behaviour seem to find a positive association between the 5-HT 2A receptor gene and the disease. 5, 6 Recently, an association was found in seasonal affective disorders, 7 disagreeing with other results. 8 In the same way, some studies found that the response to clozapine was associated with this polymorphism 9,10 although negative results were also reported. 11, 12 More recently, some authors have described the relationship between genetic variability in serotonin receptor genes (serotonin transporter and 5-HT 2A ) and different profiles of seasonality in patients with affective disorders, suggesting the possible role of certain allelic variants in the seasonal modulation of depressive symptom outcome. 7, 13 In the present study, we analysed the possible relationship between variation in the 5-HT 2A receptor gene and liability for major depression in samples of Spanish origin. Although several authors have explored the possible relationship between variability in this gene and mood disorders, results are not congruent. This is probably due to the clinical heterogeneity of the samples, which in many cases included depressive disorders (broadly defined) and bipolar cases. 4, 14 Given the allele frequencies described in the general population for the 102-T/C polymorphism in the 5-HT 2A receptor gene, our sample had 80% power (95% CI) to detect an allelic association that confers a risk greater than or equal to 2.
Genotype frequencies were in Hardy-Weinberg equilibrium for both groups, MDS patients (chi-squared = 3.92, P = 0.139) and N-MDS patients (chi-squared = 0.61, P = 0.736). No overall differences in genotype or allele frequencies were found when patients with major depression (MD) were compared to controls ( Table 1 ). The analysis of genetic data according to seasonality showed differences in genotype frequencies between depressed patients with seasonal pattern (MDS) and those with no seasonal pattern (N-MDS) (chi-squared = 10.63, df = 2, P = 0.004). The association increased when allele 102C was considered dominant: 95.1% of patients MDS carried the 102C-allele vs 72% of patients N-MDS (chi-squared = 9.45, df = 1, P = 0.002; OR = 7.57 (95% CI: 1.65-48.08)) ( Table 1) . Except for seasonality, the rest of the clinical variables considered in the study (depressive symptom severity, psychiatric family history, age of onset, presence of psychotic symptoms, number and length of episodes and admissions, melancholia and suicidal behaviour) were not found to be differentially distributed across genotypes (data not shown). Although the analysis of all these clinical variables according to the 5-HT 2A genotype involved many statistical comparisons, the association between the 5-HT 2A gene and MD with sea- sonal pattern still remained significant after Bonferroni correction (P Ͻ 0.006).
From a clinical point of view, the subgroup of patients who suffered from major depression with seasonal pattern showed an earlier age of onset, significantly higher scores for the Hamilton Depression Rating Scale, more frequent melancholia and more suicide attempts than patients with non-seasonal pattern ( Table 2) .
A recent study shows that the 5-HTTLPR polymorphism, a functional variant in the promoter region of the serotonin transporter gene, is associated with SAD and seasonality. 13 Although the 5-HT 2A 102-T/C polymorphism has also been associated with SAD, 7 the possible effect of both markers (5-HTTLPR and 102-T/C) on seasonality do not seem to be additive. 7 In a previous study we had genotyped a subset of our sample for the 5-HTTLPR polymorphism and found an association with melancholia. In the present study we analysed the possible additive effect of the 5-HTTLPR polymorphism and the 5-HT 2A 102-T/C on seasonal pattern. In agreement with Enoch et al, 7 we did not find any evidence that such an effect exists. However, the combination of 484-484 and C102-C102 genotypes was found to be more frequent in subjects with major depression than in controls (chi-squared = 4.70, P = 0.030, OR = 2.82 (95% CI: 0.99-8.40)). Seasonal changes in mood and behaviour have been reported to occur in the general population along a spectrum of severity. 15, 16 Several studies suggest that the morbid extreme of the spectrum of seasonality is constituted by seasonal affective disorder (SAD), a clinically diagnosed syndrome that tends to run in families and happens in individuals with a biological predisposition. 17 The lifetime prevalence of SAD is 0.4% in major depression and 1% in minor depression. 18 However, seasonal patterns of depressive symptoms are much more common. It has been reported that about 15% of recurrent affective disorders have a seasonal pattern. 19 Given the importance of the 5-HT function in control of behaviours that vary with seasons, including appetite, sleep, weight regulation and mood, some authors have already explored the possible role of serotonin pathway genes in the causality of SAD. A functional polymorphism located in the promoter region of the serotonin transporter gene, has been shown to be associated with seasonal affective disorder (SAD) and seasonality. 13 More recently, Enoch et al 7 found a significant increase in the frequency of the −1438A variant of the 5-HT 2A promoter polymorphism (which is in strong linkage disequilibrium with the 102T variant of the 102-T/C polymorphism) in SAD patients.
Our results in an independent sample of Spanish subjects showed that variability in the 5-HT 2A receptor was associated with seasonal pattern in major depression. Depressed patients with seasonal pattern showed an increased frequency of the 102C allele (equivalent to the −1438G variant) when compared with patients with no seasonal pattern and controls. These results are in agreement with those found for Enoch et al 7 who, as mentioned above, described an association between the 5-HT 2A gene and SAD, although in their study the association was with allele −1438A (or 102T) and it did not seem to be directly related with seasonality but with depressive symptoms of SAD. Since the 102-T/C polymorphism does not cause a change in amino acid sequence of the 5-HT 2A receptor and it has not detected functional differences according to −1438-G/A variants, these results may reflect the effect of a functional polymorphism elsewhere in the gene through linkage disequilibrium.
The fact that our subgroup of patients with seasonal pattern is also characterised by an earlier age of onset, more severe index episodes, more suicide attempts and melancholia, and shorter length of episodes, makes us think about the existence of a clinical and etiological heterogeneity within the whole group of depressed patients.
In a previous study, we already found evidence for heterogeneity in a sub-sample of these same depressed subjects. 20 An association between the 484-Stin2.10 haplotype in the serotonin transporter gene and major depression was described only in patients who strictly met DSM-IV criteria for melancholia.
Heterogeneity has classically been reported by different authors who consider major depression as a unique illness, though dynamic, variable, and pleomorphic in its clinical presentation and certainly etiologically heterogeneous. 21 According to this, depressive symptoms could be considered as a multiform sequence of states with patients commonly experiencing a variety of depressive subtypes characterised by subtle changes in course and intensity of episodes. 22 These changes might reflect the etiopathogenic differences existing among subjects and may explain the genetic differences between sub-groups of patients described in the present study.
In the near future, replication studies in large, independent and diagnostically robust samples of cases with major depression will be needed to confirm the risk that the 5-HT 2A gene seems to confer in major depression. This will also allow the diagnostic subgrouping of cases to determine if the C102 allele has consequences for specific symptoms.
Materials and methods

Subjects
One hundred and fifty-nine unrelated patients with major depression (51 men and 108 women) from the
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Mental Health Service of the Eixample district in Barcelona, and 162 healthy and unrelated controls (83 men and 81 women) from the same geographic and ethnic origin as the patients were included in the study.
Patients were diagnosed according DSM-IV criteria 23 by two experienced clinicians (LP and CG) who personally interviewed each patient. The Spanish version of the Structural Clinical Interview for DSM-III-R (SCID 24 ) was used for this purpose. Accurate information about severity of depressive symptoms, psychiatric family history, age of onset, presence of psychotic symptoms, number and length of episodes and admissions, melancholia, suicidal behaviour and seasonal pattern was also compiled.
Severity was evaluated by the 17-item Hamilton Depression Scale. 25 Family history was determined on the basis of a structured personal interview with at least one first degree relative of each proband. 26 Subjects were considered to have a positive family history of mental illness when at least one of their first degree relatives suffered from schizophrenia, schizoaffective disorder, bipolar or unipolar depression. Age at onset was defined as the age at which affective symptoms first became evident. Presence of melancholia was determined according to DSM-IV criteria. Suicidal behaviour was analysed by review of medical records and responses to a short SADS-based questionnaire applied to patients and their relatives. In the present study, we used a broad definition of seasonality: patients were considered to present a seasonal pattern of the illness simply when a regular temporal relationship between the onset and the remission of an episode and a particular period of the year existed. This definition corresponds to the first point of the DSM-IV seasonal pattern Specifier Criteria. All subjects provided informed consent to participate in the study.
On average, patients were 54.86 years old (SD = 16.21) when included in the study and controls were 41.4 years old (SD = 10.35). They had a mean age of onset of 41.42 years old (SD = 15.85) and an average of 2.70 episodes (SD = 1.95) during 13.17 years since symptoms first appeared (SD = 11.06). The mean length of episodes was 8.83 months (SD = 4.09). The mean Hamilton score at index episode was 25.99 (SD = 5.57). Among patients, 34% of subjects had a positive family history of severe psychiatric disorders and 21% had committed at least one suicide attempt.
Molecular analysis
Genomic DNA was extracted from blood samples using a standard phenol-chloroform method. The 102-T/C polymorphism in the 5-HT 2A receptor gene, which is in absolute linkage disequilibrium with the −1438-G/A variant studied by Enoch et al, 7 was genotyped according to Warren's assay 27 based on the polymerase chain reaction and subsequent MspI digestion.
Statistical analysis
Hardy-Weinberg equilibrium for genotype frequencies was tested in both patients and controls using chi-squared tests (chi-squared for controls = 0.02, P = 0.992; chi-squared for patients = 0.05, P = 0.975).
Simple chi-squared tests of independence were also performed to confirm the presence or absence of allele or genotype associations. Odds ratios (OR) with 95% confidence intervals (CI) were estimated for the effects of high-risk genotypes and alleles.
